Drugplain

edaravone 30 mg/100mL

edaravone · INJECTION, SOLUTION · XGen Pharmaceuticals DJB, Inc.

No Recall History
Plain English

edaravone is a injection, solution containing edaravone at 30 mg/100mL, taken intravenous. Manufactured by XGen Pharmaceuticals DJB, Inc..

Key Facts

Brand Name
edaravone
Generic Name
edaravone
NDC Code (Product)
39822-4500
Manufacturer
XGen Pharmaceuticals DJB, Inc.
Strength
30 mg/100mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
ANDA217565
Marketing Start
12/02/2024

Recall History

No Recall History

Frequently Asked Questions

What is edaravone used for?

edaravone contains edaravone. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is edaravone a controlled substance?

edaravone is not classified as a controlled substance by the DEA.

What is the generic name for edaravone?

The generic name for edaravone is edaravone. There are 4 other brand versions of edaravone.

What is the NDC code for edaravone 30 mg/100mL?

The NDC (National Drug Code) for edaravone 30 mg/100mL is 39822-4500, listed by XGen Pharmaceuticals DJB, Inc..

Product NDC

39822-4500

Package NDC

39822-4500-2

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)